Application of Salen-Ti complex catalysts in the preparation of quaternary carbon compounds from halogenated hydrocarbons
By using Salen-Ti complex catalysts, the Michael addition reaction of haloalkanes with Michael acceptors under aqueous conditions was catalyzed, overcoming the stringent requirement of strict anhydrous conditions in existing technologies and achieving high yield and chiral selectivity for the generation of quaternary carbon compounds.
Patent Information
- Application Number
- CN202311735794.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-18
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2043-12-18
AI Technical Summary
In existing technologies, the Michael addition reaction catalyzed from haloalkanes requires strictly anhydrous conditions, which are too demanding and make it difficult to achieve chiral selectivity.
Using Salen-Ti complexes as catalysts, a certain amount of water is allowed in the reaction system. The Michael addition reaction of tertiary halogenated hydrocarbons with Michael acceptors to form quaternary carbon compounds is catalyzed by Salen-Ti complexes. The binuclear form of the Salen-Ti complexes is used to improve the catalytic activity.
Achieving high yields of quaternary carbon compounds under aqueous conditions reduces the stringent requirements of reaction conditions and provides the possibility of chiral selectivity.
Smart Images

Figure CN117720415B_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of organic chemical catalysis, and more specifically, relates to the application of Salen-Ti complex catalysts in the preparation of quaternary carbon compounds from halogenated hydrocarbons. Background Technology
[0002] All-carbon and quaternary carbon compounds are widely found in natural products, bioactive molecules, and drug molecules, making them highly valuable for synthesis in materials, pharmaceuticals, and biochemistry. However, the steric hindrance and repulsion of the four carbon groups in quaternary carbon compounds pose significant challenges to their efficient synthesis.
[0003] Functionalization of alkenes is often considered an effective method for constructing complex molecular structures. Alkenes with electron-deficient functional groups are called Michael acceptors, such as acrylates, acrylonitriles, and vinyl phosphates, which can add to electron-rich intermediates to form new carbon-carbon bonds. Halogenated alkanes, especially chloroalkanes, are inexpensive, readily available, and stable, and are often used as starting materials in organic synthesis. Utilizing chloroalkanes to synthesize quaternary carbon compounds is an economical and convenient approach. Existing techniques disclose methods for preparing quaternary carbon compounds from chloroalkanes (Ti-Catalyzed Radical Alkylation of Secondary and Tertiary Alkyl Chlorides Using Michael Acceptors. J. Am. Chem. Soc. 2018, 140, 14836–14843.), which use water-sensitive titanium bis(oxocero) catalysts, require strictly anhydrous conditions, and the catalysts are difficult to achieve chiral selectivity. Therefore, finding a mild reaction system for preparing quaternary carbon compounds from chloroalkanes is a pressing problem in this field. Summary of the Invention
[0004] 1. The problem to be solved
[0005] To address the problem that existing technologies require strictly anhydrous conditions for the Michael addition reaction of haloalkanes, which is too demanding, this invention provides the application of Salen-Ti complex catalysts in the preparation of quaternary carbon compounds from haloalkanes. By using Salen-Ti complex catalysts to catalyze this type of Michael addition reaction, a certain amount of water can be present in the system, eliminating the need for strictly anhydrous conditions and reducing the requirements for such reaction conditions. Quaternary carbon products can still be obtained in high yields even in aqueous systems.
[0006] 2. Technical Solution
[0007] To address the aforementioned problems, this invention utilizes Salen-Ti complexes as catalysts. Salen-Ti ligands and complexes are readily synthesized, and the Salen-Ti complexes can form binuclear complexes under hydration conditions, thereby enhancing catalytic activity. The technical solution adopted in this invention is as follows:
[0008] The application of Salen-Ti complex catalysts in the preparation of quaternary carbon compounds from haloalkanes: the Michael addition reaction of tertiary haloalkanes with Michael acceptors to generate quaternary carbon compounds is catalyzed by Salen-Ti complexes.
[0009] The Salen-Ti complex is selected from any one or more of the following:
[0010]
[0011] As a preferred embodiment of the present invention, the tertiary haloalkanes are selected from one or more of tertiary chlorinated hydrocarbons, tertiary bromine hydrocarbons, or tertiary iodinated hydrocarbons. It should be noted that those skilled in the art will understand that among various haloalkanes, chlorinated hydrocarbons are less reactive in the Michael addition reaction than bromine hydrocarbons and iodinated hydrocarbons. Therefore, where chlorinated hydrocarbons can react, other haloalkanes are more readily reactive.
[0012] As a preferred embodiment of any of the present invention, the tertiary haloalkane has the structure of Formula I:
[0013]
[0014] Formula I
[0015] Wherein, R, R1, and R2 are selected from alkyl, substituted alkyl, aryl, or substituted aryl, respectively; the substituted alkyl includes haloalkyl and aryl-substituted alkyl; preferably, the alkyl or substituted alkyl is selected from alkyl or substituted alkyl with 1-10 carbon atoms;
[0016] R, R1, or R2 may be the same or different; for example, all three of R, R1, or R2 may be different from each other, or two of them may be the same, or all three may be the same.
[0017] X is selected from Cl, Br, or I.
[0018] As a preferred embodiment of any of the present invention, the Michael receptor has a structure of formula II:
[0019]
[0020]
[0021] in,
[0022] EWG is selected from -CN, -CO2R4, -SO2R4;
[0023] R4 is selected from alkyl, substituted alkyl, aryl, substituted aryl, or methylene linked to R3 in a ring; the substituted alkyl includes haloalkyl and aryl-substituted alkyl; preferably, the alkyl or substituted alkyl is selected from alkyl or substituted alkyl having 1-10 carbon atoms;
[0024] The R3 is selected from H or CH3, or is a methylene group that is cyclically linked to R4.
[0025] For example, R3 could be -CH2-, EWG could be -CO2R4, where R4 is -CH2-, and R3 and R4 are linked. Then the structure of the Michael receptor would be:
[0026] As a preferred embodiment of any of the present invention, the quaternary carbon-containing compound has the structure of Formula III:
[0027]
[0028] Formula III. The definitions of R, R1, R2, R3, and R4 can be the definitions of the corresponding substituents in any of the aforementioned embodiments.
[0029] In a preferred embodiment of any of the present invention, R1 and R2 are methyl groups;
[0030] R is selected from methyl, -(CH2)2Ph;
[0031] R3 is selected from H or methyl, or methylene group connected to R4 to form a ring;
[0032] EWG is selected from -CN, -SO2Ph, -CO2Et, -CO2tBu, -CO2Bn, -CO2CH2CF3. Alternatively, -CO2CH2-, where the methylene group is linked to R3 to form a pentagonal lactone.
[0033] As a preferred embodiment of any of the present invention,
[0034] The tertiary halogenated hydrocarbons are selected from: Where X is selected from Cl, Br or I.
[0035] As a preferred embodiment of any of the present invention, the Michael receptor is selected from:
[0036]
[0037] As a preferred embodiment of the present invention, the tertiary haloalkane undergoes a Michael addition reaction with a Michael acceptor in an aprotic solvent in the presence of a Salen-Ti complex catalyst, a metal reducing agent, water, and a weakly acidic salt to yield a quaternary carbon-containing compound. The catalytic reaction provided by the present invention allows the presence of water, eliminating the need for strictly anhydrous conditions, thus greatly facilitating the reaction.
[0038] In a preferred embodiment of the present invention, the metal reducing agent is Zn. The role of the metal reducing agent is to reduce the tetravalent Salen-Ti complex to a trivalent Salen-Ti complex, thereby realizing the catalytic cycle of the Salen-Ti complex.
[0039] As a preferred embodiment of the present invention, the weakly acidic salt is selected from triethylamine hydrochloride, pyridine hydrochloride, pyridine hydrobromide, and pyridine hydroiodide. Preferably, the weakly acidic salt is pyridine hydrobromide or pyridine hydroiodide.
[0040] As a preferred embodiment of the present invention, the aprotic solvent is selected from ethyl acetate, toluene, tetrahydrofuran, acetonitrile, and ethylene glycol dimethyl ether. Preferably, the aprotic solvent is toluene. The aprotic solvent can ensure the catalytic efficiency of the binuclear Salen-Ti complex.
[0041] As a preferred embodiment of the present invention, the volume ratio of the aprotic solvent to water is 10:(0.5-2). This volume ratio ensures the rapid in-situ formation of the binuclear Salen-Ti complex within the reaction system, promoting the reaction.
[0042] In a preferred embodiment of the present invention, the Michael addition reaction temperature is 20–40°C. More preferably, the Michael addition reaction temperature is 25–35°C. Most preferably, the Michael addition reaction temperature is 30°C.
[0043] As a preferred embodiment of the present invention, the Michael addition reaction time is 48 to 54 hours. Most preferably, the Michael addition reaction time is 52 hours.
[0044] As a preferred embodiment of the present invention, the amount of the Salen-Ti complex catalyst is not less than 10 mol% stoichiometry. For example, if the amount of tertiary haloalkanes added in the reaction is 1 equivalent, the amount of the Salen-Ti complex catalyst is not less than 0.1 equivalent.
[0045] As a preferred embodiment of any of the present invention, the specific technical approach is as follows:
[0046]
[0047] 3. Beneficial effects
[0048] Compared with the prior art, the beneficial effects of the present invention are as follows:
[0049] (1) In the prior art, the reaction of preparing quaternary carbon compounds from halogenated hydrocarbons uses titanium cadmium catalysts. These catalysts require strict anhydrous conditions when catalyzing the Michael addition reaction, which places very high demands on the experimental conditions. The Salen-Ti complex catalyst C1-C3 provided by the present invention can be used in the Michael addition reaction of preparing quaternary carbon compounds from tertiary halogenated hydrocarbons and Michael acceptors. A certain amount of water can be present in the reaction system, and strict anhydrous conditions are not required, which reduces the requirements for such reaction conditions.
[0050] (2) The Salen-Ti complex catalysts C1-C3 provided by this invention provide a new possibility for realizing chiral quaternary carbon compounds in the Michael addition reaction of preparing quaternary carbon compounds using tertiary halogenated hydrocarbons and Michael acceptors by using Salen-Ti complexes that are easy to synthesize and modify chirally as catalysts. Attached Figure Description
[0051] Figure 1 The tert-butyl 4,4-dimethyl-6-phenylhexanoate prepared in Example 1 1 H-NMR spectrum;
[0052] Figure 2 The tert-butyl 4,4-dimethyl-6-phenylhexanoate prepared in Example 1 13 C-NMR spectrum;
[0053] Figure 3 Ethyl 4,4-dimethyl-6-phenylhexanoate prepared in Example 2 1 H-NMR spectrum;
[0054] Figure 4 Ethyl 4,4-dimethyl-6-phenylhexanoate prepared in Example 2 13 C-NMR spectrum;
[0055] Figure 5 The tert-butyl 2,4,4-trimethyl-6-phenylhexanoate prepared in Example 3 1 H-NMR spectrum;
[0056] Figure 6 The tert-butyl 2,4,4-trimethyl-6-phenylhexanoate prepared in Example 3 13 C-NMR spectrum;
[0057] Figure 7This is a schematic diagram of the mechanism of the Michael addition reaction catalyzed by the Salen-Ti complex of the present invention, which involves the formation of quaternary carbon compounds from tertiary haloalkanes and Michael acceptors. Detailed Implementation
[0058] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains; the term "one or more" as used herein includes any and all combinations of one or more of the associated listed items.
[0059] Unless otherwise specified in the examples, the procedures should be performed under standard conditions or conditions recommended by the manufacturer. Reagents or instruments whose manufacturers are not specified are all commercially available products.
[0060] Temperature, quantity, and other numerical data may be presented in range format herein. It should be understood that such range format is used solely for convenience and brevity and should be flexibly interpreted to include not only the values explicitly stated as the limits of the range, but also all individual values or subranges encompassed within the range, as if each value and subrange were explicitly stated. For example, a range of values from about 1 to about 4.5 should be interpreted to include not only the explicitly stated limits of 1 to 4.5, but also individual numbers (such as 2, 3, 4) and subranges (such as 1 to 3, 2 to 4, etc.). The same principle applies to ranges that describe only a single value, such as "less than about 4.5," which should be interpreted to include all the aforementioned values and ranges. Furthermore, this interpretation should apply regardless of the breadth of the range or characteristic described.
[0061] The scope of this invention should be determined solely by the appended claims and their legal equivalents, and not by the description and examples given herein.
[0062] The present invention will be further described below with reference to specific embodiments.
[0063] Salen-Ti complexes can be prepared using existing techniques. For example, the preparation route for Salen-Ti complex C3 is as follows:
[0064]
[0065] 3-(tert-butyl)-2-hydroxy-5-methoxybenzaldehyde (2.0 equivalents) and cyclohexanediamine (1.0 equivalents) were dissolved in ethanol, refluxed in a round-bottom flask for two hours, and then cooled and recrystallized to obtain the crude product Salen ligand.
[0066] The Salen ligand was added to a dry Schlenk flask, evacuated and purged with argon three times, and then dry tetrahydrofuran was added. The system was then cooled at -78°C, and a toluene solution of titanium tetrachloride was slowly added dropwise. The mixture was then refluxed for two hours, cooled, concentrated and evaporated, and recrystallized with petroleum ether and ethyl acetate to obtain a clean Salen-Ti complex C3.
[0067] The preparation route of Salen-Ti complex C1 can be found in the literature ((Salen)Titanium-Catalyzed AsymmetricHydrogen Atom Transfer for Epoxides Reduction. Angew. Chem. Int. Ed. 2022, 61, e202214111.), the difference being that the raw material in that literature is chiral, while the raw material used in the preparation of C1 in this invention is a racemic compound.
[0068] The preparation route for Salen-Ti complex C2 can be found in the literature (Reactivity of AlMe3 with titanium(IV)Schiff base complexes: X-ray structure of [Ti{(μ-Br)(AlMe2)}{(μ-Br)(AlMe2X)}(salen)]·C7H8(X=Me or Br) and reactivity studies of mono-alkylated [Ti(Me)X(L)]complexes. Journal of Organometallic Chemistry. 1999, 580, 304-312.)
[0069] Example 1
[0070] Synthesis of tert-butyl 4,4-dimethyl-6-phenylhexanoate
[0071]
[0072] Salen-Ti complex C3 (0.02 mmol, 12 mg), zinc powder (approximately 0.8 mmol, 52 mg), and pyridine hydroiodide (0.6 mmol, 124 mg) were added to a 10 mL dry Schlenk tube, and the mixture was evacuated and purged with argon three times. Then, 1 mL of toluene and 100 μL of distilled water were added, and the mixture was stirred at 30 °C for 1.5 h. Next, 3-chloro-3-methylbutyrate (0.2 mmol, 36 mg) and tert-butyl acrylate (0.4 mmol, 58 μL) were added sequentially, and the mixture was stirred at 30 °C for 52 h. After the reaction was complete, the mixture was subjected to column chromatography (eluent: petroleum ether: diethyl ether = 19:1) to give 50 mg of the oily product tert-butyl 4,4-dimethyl-6-phenylhexanoate, with a yield of 90%.
[0073] 1 H NMR (400MHz, CDCl3): δ7.23–7.16(m,2H),7.14–7.05(m,3H),2.48(d,J=17.6Hz,2H),2 .23–2.03(m,2H),1.54–1.49(m,2H),1.42(d,J=17.6Hz,2H),1.37(s,9H),0.86(s,6H);
[0074] 13 C NMR (101MHz, CDCl3): δ172.7,142.2,127.3,127.3,124.6,79.0,43.1,35.4,31.6,29.8,29.6,27.1,25.7.
[0075] Example 2
[0076] Synthesis of ethyl 4,4-dimethyl-6-phenylhexanoate
[0077]
[0078] Salen-Ti complex C3 (0.02 mmol, 12 mg), zinc powder (0.8 mmol, 52 mg), and pyridine hydroiodide (0.6 mmol, 124 mg) were added to a 10 mL dry Schlenk tube, and the mixture was evacuated and purged with argon three times. Then, 1 mL of toluene and 100 μL of distilled water were added, and the mixture was stirred at 30 °C for 1.5 h. Next, 3-chloro-3-methylbutyrate (0.2 mmol, 36 mg) and ethyl acrylate (0.4 mmol, 43 μL) were added sequentially, and the mixture was stirred at 30 °C for 52 h. After the reaction was complete, the mixture was subjected to column chromatography (eluent: petroleum ether: diethyl ether = 19:1) to give 40 mg of the oily product ethyl 4,4-dimethyl-6-phenylhexanoate, with a yield of 81%.
[0079] 1 H NMR (500MHz, CDCl3): δ7.19 (dd, J=11.8, 4.9Hz, 2H), 7.10 (d, J=7.1Hz, 3H), 4.06 (q, J=7.1Hz, 2H), 2.5 5–2.43(m,2H),2.27–2.11(m,2H),1.63–1.54(m,2H),1.44(s,2H),1.18(t,J=7.1Hz,3H),0.87(s,6H);
[0080] 13 C NMR (101MHz, CDCl3): δ172.8,142.2,127.3,127.3,124.6,79.0,43.1,35.4,31.6,29.8,29.6,27.1,25.7.
[0081] Example 3
[0082] Synthesis of tert-butyl 2,4,4-trimethyl-6-phenylhexanoate
[0083]
[0084] Salen-Ti complex C3 (0.02 mmol, 12 mg), zinc powder (0.8 mmol, 52 mg), and pyridine hydroiodide (0.6 mmol, 124 mg) were added to a 10 mL dry Schlenk tube, and the mixture was evacuated and purged with argon three times. Then, 1 mL of toluene and 100 μL of distilled water were added, and the mixture was stirred at 30 °C for 1.5 h. Next, 3-chloro-3-methylbutyrate (0.2 mmol, 36 mg) and tert-butyl methacrylate (0.4 mmol, 65 μL) were added sequentially, and the mixture was stirred at 30 °C for 52 h. After the reaction was complete, the mixture was subjected to column chromatography (eluent: petroleum ether: diethyl ether = 19:1) to give 49 mg of the oily product tert-butyl 2,4,4-trimethyl-6-phenylhexanoate, with a yield of 84%.
[0085] 1 H NMR (400MHz, CDCl3): δ7.19(dd,J=9.7,5.1Hz,2H),7.10(dd,J=7.9,2.0Hz,3H),2.58–2.41(m,2H),2.37–2.27(m,1H),1.83(dd, J=14.2,9.0Hz,1H),1.43(dd,J=9.3,8.3Hz,2H),1.34(s,9H),1.11(dd,J=14.2,2.8Hz,1H),1.06(d,J=7.1Hz,3H),0.86(s,6H);
[0086] 13 C NMR (101MHz, CDCl3): δ176.2,142.3,127.29,127.26,124.5,78.7,44.5,43.7,35.7,32.4,29.7,26.9,25.9,25.8,19.6.
[0087] Example 4
[0088] Synthesis of 2,2,2-trifluoroethyl-4,4-dimethyl-6-phenylhexanoate
[0089]
[0090] Salen-Ti complex C3 (0.02 mmol, 12 mg), zinc powder (0.8 mmol, 52 mg), and pyridine hydroiodate (0.6 mmol, 124 mg) were added to a 10 mL dry Schlenk tube, and the mixture was evacuated and purged with argon three times. Then, 1 mL of toluene and 100 μL of distilled water were added, and the mixture was stirred at 30 °C for 1.5 h. Next, 3-chloro-3-methylbutyrate (0.2 mmol, 36 mg) and 2,2,2-trifluoroethyl acrylate (0.4 mmol, 51 μL) were added sequentially, and the mixture was stirred at 30 °C for 52 h. After the reaction was complete, the mixture was subjected to column chromatography (eluent: petroleum ether: diethyl ether = 19:1) to give 32 mg of the oily product 2,2,2-trifluoroethyl-4,4-dimethyl-6-phenylhexanoate, with a yield of 53%.
[0091] 1 H NMR (400MHz, CDCl3): δ7.28–7.18(m,2H),7.10(dd,J=7.3,4.2Hz,3H),4.39(q,J=8.5Hz,2H),2. 56–2.45(m,2H),2.40–2.27(m,2H),1.59(dd,J=9.6,7.2Hz,2H),1.48–1.36(m,2H),0.88(s,6H);
[0092] 13 C NMR (101MHz, CDCl3): δ171.7, 141.9, 127.4, 127.2, 124.7, 122.0 (q, J = 279.8Hz), 59.2 (q, J = 36.4Hz), 42.9, 35.1, 31.6, 29.6, 28.0, 25.6.
[0093] Example 5
[0094] Synthesis of 4,4-dimethyl-6-phenylhexanenitrile
[0095]
[0096] Salen-Ti complex C3 (0.02 mmol, 12 mg), zinc powder (0.8 mmol, 52 mg), and pyridine hydroiodide (0.6 mmol, 124 mg) were added to a 10 mL dry Schlenk tube, and the mixture was evacuated and purged with argon three times. Then, 1 mL of toluene and 100 μL of distilled water were added, and the mixture was stirred at 30 °C for 1.5 h. Next, 3-chloro-3-methylbutyrate (0.2 mmol, 36 mg) and acrylonitrile (0.4 mmol, 26 μL) were added sequentially, and the mixture was stirred at 30 °C for 52 h. After the reaction was complete, the mixture was subjected to column chromatography (eluent: petroleum ether: diethyl ether = 19:1) to give 16 mg of the oily product 4,4-dimethyl-6-phenylhexanoate, with a yield of 40%.
[0097] 1 H NMR (400MHz, CDCl3): δ7.26–7.20(m,2H),7.15–7.07(m,3H),2.58–2.41(m,2H), 2.30–2.14(m,2H),1.63(dd,J=9.0,7.3Hz,2H),1.47–1.40(m,2H),0.91(s,6H);
[0098] 13 C NMR (101MHz, CDCl3): δ141.5,127.4,127.2,124.8,119.4,42.6,36.2,31.9,29.5,25.3,11.4.
[0099] Example 6
[0100] Synthesis of (3,3-dimethyl-5-(phenylsulfonyl)pentyl)benzene
[0101]
[0102] Salen-Ti complex C3 (0.02 mmol, 12 mg), zinc powder (0.8 mmol, 52 mg), and pyridine hydroiodide (0.6 mmol, 124 mg) were added to a 10 mL dry Schlenk tube, and the mixture was evacuated and purged with argon three times. Then, 1 mL of toluene and 100 μL of distilled water were added, and the mixture was stirred at 30 °C for 1.5 h. Next, 3-chloro-3-methylbutyrobenzene (0.2 mmol, 36 mg) and phenyl vinyl sulfone (0.4 mmol, 67 mg) were added sequentially, and the mixture was stirred at 30 °C for 52 h. After the reaction was complete, the mixture was subjected to column chromatography (eluent: petroleum ether: ethyl acetate = 5:1) to give 22 mg of the oily product (3,3-dimethyl-5-(phenylsulfonyl)pentyl)benzene, with a yield of 35%.
[0103] 1 H NMR (400MHz, CDCl3): δ7.91–7.81(m,2H),7.58(dd,J=5.0,3.7Hz,1H),7.55–7.48(m,2H),7.21–7.16(m,2H),7.11(d,J= 7.4Hz,1H),7.06–7.00(m,2H),3.07–2.89(m,2H),2.43–2.27(m,2H),1.72–1.52(m,2H),1.40–1.31(m,2H),0.84(s,6H);
[0104] 13 C NMR (101MHz, CDCl3): δ142.5,139.1,133.7,129.3,128.4,128.2,128.1,125.8,52.5,43.8,33.6,32.7,30.4,26.7.
[0105] Example 7
[0106] Synthesis of benzyl 4,4-dimethyl-6-phenylhexanoate
[0107]
[0108] Salen-Ti complex C3 (0.02 mmol, 12 mg), zinc powder (0.8 mmol, 52 mg), and pyridine hydroiodide (0.6 mmol, 124 mg) were added to a 10 mL dry Schlenk tube, and the mixture was evacuated and purged with argon three times. Then, 1 mL of toluene and 100 μL of distilled water were added, and the mixture was stirred at 30 °C for 1.5 h. Next, 3-chloro-3-methylbutyrate (0.2 mmol, 36 mg) and benzyl acrylate (0.4 mmol, 60 μL) were added sequentially, and the mixture was stirred at 30 °C for 52 h. After the reaction was complete, the mixture was subjected to column chromatography (eluent: petroleum ether: diethyl ether = 19:1) to give 50 mg of the oily product 4,4-dimethyl-6-phenylhexanoate, with a yield of 80%.
[0109] 1 H NMR (500MHz, CDCl3): δ7.41–7.32(m,4H),7.30–7.24(m,4H),7.17(dd,J=7.3,5.0Hz,2H),5.12( s,2H),2.64–2.51(m,2H),2.45–2.29(m,2H),1.74–1.62(m,2H),1.53–1.45(m,2H),0.94(s,6H);
[0110] 13 C NMR (101MHz, CDCl3): δ174.2,143.1,136.1,131.3,128.6,128.4,128.30, 128.26,128.23,128.19,125.6,66.3,44.0,36.4,32.7,30.6,29.6,26.7.
[0111] Example 8
[0112] Synthesis of cyclohexyl 4,4-dimethyl-6-phenylhexanoate
[0113]
[0114] Salen-Ti complex C3 (0.02 mmol, 12 mg), zinc powder (0.8 mmol, 52 mg), and pyridine hydroiodide (0.6 mmol, 124 mg) were added to a 10 mL dry Schlenk tube, and the mixture was evacuated and purged with argon three times. Then, 1 mL of toluene and 100 μL of distilled water were added, and the mixture was stirred at 30 °C for 1.5 h. Next, 3-chloro-3-methylbutyrate (0.2 mmol, 36 mg) and cyclohexyl acrylate (0.4 mmol, 63 μL) were added sequentially, and the mixture was stirred at 30 °C for 52 h. After the reaction was complete, the mixture was subjected to column chromatography (eluent: petroleum ether: diethyl ether = 19:1) to give 51 mg of the oily product cyclohexyl 4,4-dimethyl-6-phenylhexanoate, with a yield of 85%.
[0115] 1 H NMR (400MHz, CDCl3): δ7.20(dd,J=9.4,5.2Hz,2H),7.13–7.03(m,3H),4.68(dt,J=9.0,4.7Hz,1H),2.60–2.42(m,2H),2.28–2.13(m,2H),1.85 –1.75(m,2H),1.65(dd,J=8.9,3.2Hz,2H),1.55(ddd,J=11.7,7.0,3.0Hz,2H),1.49–1.40(m,3H),1.36–1.25(m,4H),1.18(s,1H),0.87(s,6H);
[0116] 13 C NMR (101MHz, CDCl3): δ172.8,142.2,127.3,127.3,124.6,71.4,43.0,35.5,31.7,30.6,29.6,29.0,25.7,24.4,22.8.
[0117] Example 9
[0118] Synthesis of 3-(2,2-dimethyl-4-phenylbutyl)dihydrofuran-2(3H)-one
[0119]
[0120] Salen-Ti complex C3 (0.02 mmol, 12 mg), zinc powder (0.8 mmol, 52 mg), and pyridine hydroiodide (0.6 mmol, 124 mg) were added to a 10 mL dry Schlenk tube, and the mixture was evacuated and purged with argon three times. Then, 1 mL of toluene and 100 μL of distilled water were added, and the mixture was stirred at 30 °C for 1.5 h. Next, 3-chloro-3-methylbutyrobenzene (0.2 mmol, 36 mg) and α-methylene-γ-butyrolactone (0.4 mmol, 70 μL) were added sequentially, and the mixture was stirred at 30 °C for 52 h. After the reaction was complete, the mixture was subjected to column chromatography (eluent: petroleum ether: diethyl ether = 19:1) to give 16 mg of the oily product 3-(2,2-dimethyl-4-phenylbutyl)dihydrofuran-2(3H)-one, with a yield of 33%.
[0121] 1 H NMR (300MHz, CDCl3): δ7.37–7.26(m,2H),7.18(dd,J=7.0,3.7Hz,3H),4.35(td,J=9.1,1.5Hz,1H),4.24–4.05(m,1H),2.68–2.42(m ,4H),2.15(dd,J=14.3,1.9Hz,1H),1.99(ddd,J=9.2,8.0,4.4Hz,1H),1.60–1.51(m,2H),1.40–1.29(m,1H),1.01(d,J=0.6Hz,6H);
[0122] 13 C NMR (101MHz, CDCl3): δ172.8,142.2,127.3,127.3,124.6,79.0,43.1,35.4,31.6,29.8,29.6,27.1,25.7.
[0123] Example 10
[0124] Synthesis of tert-butyl 4,4-dimethylvalerate
[0125]
[0126] Salen-Ti complex C3 (0.02 mmol, 12 mg), zinc powder (0.8 mmol, 52 mg), and pyridine hydroiodide (0.6 mmol, 124 mg) were added to a 10 mL dry Schlenk tube, and the mixture was evacuated and purged with argon three times. Then, 1 mL of toluene and 100 μL of distilled water were added, and the mixture was stirred at 30 °C for 1.5 h. Next, tert-butyl chloride (0.2 mmol, 18 mg) and tert-butyl acrylate (0.4 mmol, 58 μL) were added sequentially, and the mixture was stirred at 30 °C for 52 h. After the reaction was complete, the mixture was subjected to column chromatography (eluent: petroleum ether: diethyl ether = 19:1) to give 27 mg of the oily product tert-butyl 4,4-dimethylvalerate, with a yield of 73%.
[0127] 1 H NMR (400MHz, CDCl3): δ2.26–2.08(m,2H),1.54–1.47(m,2H),1.44(s,9H),0.89(s,9H).
[0128] 13 C NMR (101MHz, CDCl3): δ172.9,78.9,37.6,30.3,29.0,28.0,27.1.
[0129] The mechanism of the Michael addition reaction catalyzed by the Salen-Ti complex in this invention, which involves the formation of quaternary carbon compounds from tertiary haloalkanes using Michael acceptors, is as follows: Figure 7 As shown, the tetravalent Salen-Ti complex is first reduced to a trivalent dinuclear Salen-Ti complex in the presence of zinc powder and water. Then, it undergoes catalytic reduction of a tertiary chlorinated hydrocarbon to a tertiary radical intermediate. This tertiary radical intermediate is then captured by a Michael acceptor to form a new radical intermediate, which is subsequently reduced again by the trivalent dinuclear Salen-Ti complex to a negative ion. This negative ion then undergoes proton hydrogen addition with a weakly acidic salt to yield the final quaternary carbon product.
[0130] The above description provides an illustrative overview of the present invention and its embodiments. This description is not restrictive, and the embodiments shown are merely one example of the invention's implementation. Actual implementations are not limited to these examples. Therefore, if those skilled in the art are inspired by this description and design similar implementations and examples without departing from the spirit of the invention, such designs should fall within the scope of protection of the present invention.
Claims
1. The application of Salen-Ti complex catalysts in the preparation of quaternary carbon compounds from haloalkanes, characterized in that, The Michael addition reaction of tertiary halogenated hydrocarbons with Michael acceptors to generate quaternary carbon compounds was catalyzed using Salen-Ti complexes. The Salen-Ti complex is selected from any one or more of the following: , , ; The tertiary halohydrocarbon has the structure of Formula I: Formula I Wherein, R, R1, and R2 are selected from alkyl, substituted alkyl, aryl, or substituted aryl groups, respectively; R, R1, or R2 may be the same or different; X is selected from Cl, Br, or I; The Michael receptor has a structure of formula II: Formula II in, EWG is selected from -CN, -CO2R4, -SO2R4, ; R4 is selected from alkyl, substituted alkyl, aryl, substituted aryl, or methylene linked to R3 to form a ring; R3 is selected from H or CH3, or, or is a methylene group cyclically linked to R4; The quaternary carbon-containing compound has the structure of formula III: Formula III; The tertiary haloalkanes undergo a Michael addition reaction with a Michael acceptor in an aprotic solvent in the presence of Salen-Ti complex catalyst, metal reducing agent, water, and weakly acidic salt to yield a quaternary carbon-containing compound. The metal reducing agent is Zn; The weakly acidic salt is selected from triethylamine hydrochloride, pyridine hydrochloride, pyridine hydrobromide, and pyridine hydroiodide. The aprotic solvent is selected from ethyl acetate, toluene, tetrahydrofuran, acetonitrile, and ethylene glycol dimethyl ether.
2. The application according to claim 1, characterized in that, in, R1 and R2 are methyl groups; R is selected from methyl, -(CH2)2Ph; R3 is selected from H or methyl, or methylene group connected to R4 to form a ring; EWG is selected from -CN, -SO2Ph, -CO2Et, -CO2 t Bu, -CO2Bn, -CO2CH2CF3, , or -CO2CH2-, where the methylene group is linked to R3 to form a pentagonal lactone.
3. The application according to claim 1, characterized in that, The tertiary halogenated hydrocarbons are selected from: , Where X is selected from Cl, Br, or I; The Michael receptor is selected from: , , , , , , , , .
4. The application according to claim 1, characterized in that: The Michael addition reaction temperature is 20~40℃; The amount of the Salen-Ti complex used is not less than 10 mol% stoichiometry.
